- Clinical Trials
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1068EUR$1,200USD£940GBP
€1335EUR$1,500USD£1,175GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €890EUR$1,000USD£783GBP
€1112EUR$1,250USD£979GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1068EUR$1,200USD£940GBP
€1335EUR$1,500USD£1,175GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1068EUR$1,200USD£940GBP
€1335EUR$1,500USD£1,175GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Report
- December 2024
- 70 Pages
Global
From €2812EUR$3,160USD£2,475GBP
€3515EUR$3,950USD£3,094GBP
- Report
- December 2024
- 119 Pages
Global
From €2812EUR$3,160USD£2,475GBP
€3515EUR$3,950USD£3,094GBP
- Report
- December 2024
- 30 Pages
Global
From €2314EUR$2,600USD£2,037GBP
€2892EUR$3,250USD£2,546GBP
- Report
- May 2025
- 112 Pages
Global
From €4227EUR$4,750USD£3,721GBP
- Report
- April 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,517GBP
- Report
- April 2025
- 250 Pages
Global
From €3995EUR$4,490USD£3,517GBP
- Report
- September 2025
- 146 Pages
Global
From €2268EUR$2,549USD£1,997GBP
€2669EUR$2,999USD£2,349GBP
- Report
- October 2025
- 188 Pages
Global
From €3155EUR$3,545USD£2,777GBP
€3505EUR$3,939USD£3,085GBP
- Report
- August 2025
- 184 Pages
Global
From €3155EUR$3,545USD£2,777GBP
€3505EUR$3,939USD£3,085GBP
The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more
